William Finn, MD

Elie G. Dib, MD, MS, FACP, is board-certified in hematology and medical oncology. He has a special interest in treating cancer with innovative therapies including immunotherapy and targeted therapy. Dr. Dib completed his postgraduate education at Harvard Medical School in cancer biology research with a special focus on cancer immunotherapy and genomics. He also holds a Master of Science in Individualized Genomics and Health from Johns Hopkins University. Dr. Dib treats patients with a variety of malignancies especially malignant hematological diseases (including lymphoma, multiple myeloma, leukemia, myelodysplastic syndrome and other bone marrow disorders) as well as other tumors including breast cancer, melanoma, lung cancer, head and neck cancers, gastrointestinal cancers, sarcomas and urologic cancers. He is a fellow of the American College of Physicians and serves as the associate program director for the Hematology Oncology Fellowship at Trinity Health Ann Arbor Hospital. Dr. Dib is an Adjunct Faculty Lecturer at Johns Hopkins University where he teaches Cancer Genomics

Tareq Al Baghdadi, MD, is board-certified in hematology and medical oncology. He has clinical interests in hematology, breast and urologic cancers. Dr. Al Baghdadi has additional training in acquired and inherited coagulation and bleeding disorders.

Radhika Takiar, MD is a board-certified in Hematology and Oncology.